Arrowhead Pharma director Michael S. Perry disposes of 11,600 shares for $1.01 million
ARWR•Insider sale disclosed
- Arrowhead Pharmaceuticals director Michael S. Perry sold 11,600 common shares on Aug. 18, 2026.
- The sale was priced at $87.3 per share.
